Cited by 133Antifungal resistance and susceptibilityNeutropenia and Cancer InfectionsImmunodeficiency and Autoimmune Disorders

Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis

Heng, Siow Chin, Morrissey, Orla, Chen, Sharon C-A, Thursky, Karin, Manser, Renee L, Nation, Roger L, Kong, David C-M, Slavin, Monica·2015·Critical Reviews in Microbiology

Abstract

BACKGROUND: The clinical utility of bronchoalveolar lavage (BAL) fluid galactomannan (GM) for the early diagnosis of invasive aspergillosis (IA) varies widely across studies mainly due to heterogeneity of the studied populations. METHODS: We conducted a systematic review and meta-analysis of 16 studies involving 783 adults with hematological malignancies to derive summary estimates of the overall accuracy of BAL-GM for diagnosing IA. FINDINGS: Summary estimates of BAL-GM using an optical density (OD) index cutoff value of 1.5 for proven and probable IA were: sensitivity 0.92 (95% CI = 0.48-0.99), specificity 0.98 (95% CI = 0.78-1.00), positive likelihood ratio 53.7 (95% CI = 3.7-771.8), and negative likelihood ratio 0.08 (95% CI = 0.01-0.83). Comparing serum GM and Aspergillus PCR testing on BAL fluid, BAL-GM conferred greater sensitivity, but lower specificity than the serum GM test, and similar specificity as the PCR assay. The use of BAL-GM with serum GM or BAL-PCR tests increased the sensitivity moderately when a positive result was defined by either assay. INTERPRETATION: GM quantification in BAL fluid at an OD index cutoff value of 1.5 has excellent sensitivity and specificity to assist clinical decision-making in confirming or excluding a diagnosis of IA when results are interpreted with clinical findings. Additional research investigating the effects of antifungal agents, optimal timing and processing of BAL sampling are needed to improve the diagnostic accuracy of BAL-GM testing.

Integrity signals

Registry

Crossref · 10.3109/1040841x.2013.804033

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies showed that BAL fluid GM has improved sensitivity compared to serum GM in high-risk patients with IPA, including nonneutropenic patients.

    “Recent studies showed that BAL fluid GM has improved sensitivity compared to serum GM in high-risk patients with IPA, including nonneutropenic patients (88, 114–119).”

    From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [115]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Heng, S. C., Morrissey, O., Chen, S. C.-A., Thursky, K., Manser, R. L., Nation, R. L., Kong, D. C.-M., & Slavin, M.
Affiliations
  • Monash University (AU)
  • The Alfred Hospital (AU)
  • Westmead Hospital (AU)
  • Peter MacCallum Cancer Centre (AU)
Corresponding author
Slavin, Monica
Venue
Critical Reviews in Microbiology
Published
2013-06-25
Volume
41
Issue
1
Pages
124-134
ISSN
  • 1040-841X (ISSN-L)
  • 1549-7828
OpenAlex
W2084293582
Cited by
133
References
80
Citations by year
2026: 1 · 2025: 10 · 2024: 6 · 2023: 12 · 2022: 9 · 2021: 8 · 2020: 10 · 2019: 13 · 2018: 15 · 2017: 11 · 2016: 11 · 2015: 11 · 2014: 16
FWCI
1.64
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Reviews in Microbiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Keywords
invasive aspergillosis, bronchoalveolar lavage fluid, galactomannan, Aspergillus PCR, hematologic malignancies, diagnostic accuracy, sensitivity and specificity, serum galactomannan
MeSH terms
Adult, Aspergillosis, Bronchoalveolar Lavage Fluid, Galactose, Humans, Mannans, Sensitivity and Specificity, Polymerase Chain Reaction, Hematologic Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review